English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Mirati Therapeutics
Press release submission
| Sep 19, 2021
Mirati Therapeutics Presents Positive Clinical Data with Investigational Adagrasib as Monotherapy and in Combination with Cetuximab in Patients with KRAS G12C-Mutated Colorectal Cancer
Trending
+
Pharmaceuticals
Patient Daily
| Feb 4, 2025
Miami's firefighters climb stairs for lung disease awareness
+
Pharmaceuticals
Patient Daily
| Feb 4, 2025
American Lung Association launches PSAs promoting early detection for lung cancer
